Impact of Direct-to-Consumer Predictive Genomic Testing on Risk Perception and Worry Among Patients Receiving Routine Care in a Preventive Health Clinic
Authors:
- Clayton T. CowlCCClayton T. Cowl
- Jon C. TilburtJTJon C. Tilburt
- Pamela S. SinicropePSPamela S. Sinicrope
- Marguerite E. RobinsonMRMarguerite E. Robinson
- Katrin R. FrimannsdottirKFKatrin R. Frimannsdottir
- Kristina TiedjeKTKristina Tiedje
- Barbara A. KoenigBKBarbara A. Koenig
- 1 October 2011
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 86 (10) , 933-940
Abstract
No abstract availableKeywords
Funding Information
- Mayo Clinic
This publication has 27 references indexed in Scilit:
- Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease RiskNew England Journal of Medicine, 2011
- Bioethical and Clinical Dilemmas of Direct-to-Consumer Personal Genomic Testing: The Problem of Misattributed EquivalenceScience Translational Medicine, 2010
- The Scientific Foundation for Personal Genomics: Recommendations from a National Institutes of Health–Centers for Disease Control and Prevention Multidisciplinary WorkshopGenetics in Medicine, 2009
- Social Networkers' Attitudes Toward Direct-to-Consumer Personal Genome TestingThe American Journal of Bioethics, 2009
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- An Unwelcome Side Effect of Direct-to-Consumer Personal Genome TestingJAMA, 2008
- Knowing me, knowing youBMJ, 2008
- A Critical Appraisal of the Scientific Basis of Commercial Genomic Profiles Used to Assess Health Risks and Personalize Health InterventionsThe American Journal of Human Genetics, 2008
- Prediction of individual genetic risk to disease from genome-wide association studiesGenome Research, 2007
- ACMG Statement on Direct-to-Consumer Genetic TestingGenetics in Medicine, 2004